




Healthcare Industry News: radiosurgery
News Release - July 15, 2010
Elekta to Highlight Intelligent Cancer Management Solutions at 2010 AAPM Annual Meeting
PHILADELPHIA, July 15 -- (Healthcare Sales & Marketing Network) -- At the 2010 American Association of Physicists in Medicine (AAPM) Annual Meeting, July 18 - 20 in Philadelphia, Elekta (booth #101) will showcase its broad array of intelligent solutions for radiation therapy planning, oncology information management and Image Guided Radiation Therapy."At Elekta, intelligent solutions originate from collaboration with medical professionals, resulting in systems that truly meet our customers' needs," says Jay Hoey, Executive Vice President for Elekta North America. "Intelligence is built into all of our products, not only streamlining the radiation therapy process, but also giving clinicians the confidence they need to provide the highest quality patient care."
Elekta will also be demonstrating Clarity™, the latest addition to the Elekta product portfolio. Clarity provides non-invasive soft tissue visualization to support radiation therapy workflows. Using latest generation 3D ultrasound specifically designed for radiation therapy, Clarity compares 3D structures—not images—to provide accurate guidance non-invasively, without additional dose or any compromise to throughput.
Representing the latest advance in 4D image guidance, Elekta's XVI now offers intelligent motion management and guidance. Symmetry™ motion management provides imaging tools to manage shifts in the relative positions of the tumor and organs-at-risk during the respiratory cycle. Intuity™ provides critical structure avoidance by accounting more accurately for both the position of the tumor and the healthy critical structures.
Elekta also will show the new version of Atlas-based Auto-segmentation (ABAS) 2.0 software, which includes the Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm to increase segmentation accuracy. ABAS deforms atlases of anatomy previously defined on a reference image onto a new patient image, creating a new structure set fit to the patient anatomy and enhancing planning efficiency.
Intelligent planning for Elekta VMAT is also available through Monaco with VMAT®, which helps clinicians plan around structures effectively for Elekta VMAT delivery and predict the total dose the patient will receive.
To streamline the entire medical oncology or radiation oncology workflow, Elekta offers the MOSAIQ® oncology information system. Through its image-enabled electronic medical record (EMR), MOSAIQ helps centers coordinate information management involving diagnosis and staging, planning, treatment and follow-up.
To discover how intelligent solutions from Elekta can meet your real-world challenges—with service that is unmatched in the industry—visit www.elekta.com/intelligence.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Source: Elekta
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.